Curt Wolfgang, Ph.D.
VP Program Director
Curt Wolfgang is the VP Program Director for Fanapt™ (iloperidone). Dr. Wolfgang joined Vanda from Novartis Pharmaceuticals, where he worked from 2001-2003 as a Senior Scientist for the Clinical Pharmacogenetics department. During this time, he served on multiple International Project Teams in the transplantation therapeutic area.
Prior to joining Novartis, he was a Postdoctoral fellow at the National Cancer Institute Identifying novel genes specifically expressed in human prostate for the development of immunotoxins against metastatic forms of prostate cancer. He has a B. S. from The Pennsylvania State University and a Ph.D. from The Ohio State University.
« return to management